182 related articles for article (PubMed ID: 8600623)
1. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation.
Suzuki S; Enosawa S; Kakefuda T; Shinomiya T; Amari M; Naoe S; Hoshino Y; Chiba K
Transplantation; 1996 Jan; 61(2):200-5. PubMed ID: 8600623
[TBL] [Abstract][Full Text] [Related]
2. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.
Li XK; Tamura A; Fujino M; Guo L; Kakefuda T; Funeshima N; Enosawa S; Amari M; Naoe S; Amemiya H; Suzuki S
Clin Exp Immunol; 2001 Feb; 123(2):331-9. PubMed ID: 11207666
[TBL] [Abstract][Full Text] [Related]
3. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats.
Ueda H; Takahara S; Azuma H; Kusaka M; Suzuki S; Katsuoka Y
Eur Surg Res; 2000; 32(5):279-83. PubMed ID: 11111172
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
[TBL] [Abstract][Full Text] [Related]
5. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs.
Furukawa H; Suzuki T; Jin MB; Yamashita K; Taniguchi M; Magata S; Ishikawa H; Ogata K; Masuko H; Shimamura T; Fukai M; Hayashi T; Fujita M; Nagashima K; Omura T; Kishida A; Todo S
Transplantation; 2000 Jan; 69(2):235-41. PubMed ID: 10670633
[TBL] [Abstract][Full Text] [Related]
7. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
[TBL] [Abstract][Full Text] [Related]
8. Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation.
Xu M; Pirenne J; Antoniou EA; Afford SC; D'Silva M; McMaster P
Transpl Int; 1998; 11(4):288-94. PubMed ID: 9704394
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
[TBL] [Abstract][Full Text] [Related]
11. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation.
Mitsusada M; Suzuki S; Kobayashi E; Enosawa S; Kakefuda T; Miyata M
Transpl Int; 1997; 10(5):343-9. PubMed ID: 9287398
[TBL] [Abstract][Full Text] [Related]
12. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
Wang MH; Milekhin V; Zhang H; Huang HZ
Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
[TBL] [Abstract][Full Text] [Related]
13. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival.
Yanagawa Y; Hoshino Y; Chiba K
Int J Immunopharmacol; 2000 Aug; 22(8):597-602. PubMed ID: 10988354
[TBL] [Abstract][Full Text] [Related]
14. A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus.
Shimizu C; Li X; Kimura M; Hashimoto K; Sugaya K; Kubo M; Suzuki S; Nakayama T
Immunology; 1998 Aug; 94(4):503-12. PubMed ID: 9767438
[TBL] [Abstract][Full Text] [Related]
15. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
16. FTY720: A new kid on the block for transplant immunosuppression.
Aki FT; Kahan BD
Expert Opin Biol Ther; 2003 Jul; 3(4):665-81. PubMed ID: 12831371
[TBL] [Abstract][Full Text] [Related]
17. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.
Hwang MW; Matsumori A; Furukawa Y; Ono K; Okada M; Iwasaki A; Hara M; Sasayama S
Circulation; 1999 Sep; 100(12):1322-9. PubMed ID: 10491378
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of mycophenolate sodium as monotherapy and in combination with FTY720 in a DA-to-Lewis-rat heart-transplantation model.
Matsumoto Y; Hof A; Baumlin Y; Hof RP
Transplantation; 2002 Nov; 74(10):1372-6. PubMed ID: 12451233
[TBL] [Abstract][Full Text] [Related]
19. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term administration of low-dose FTY720 on survival of murine cardiac allograft.
Cheng Q; Li D; Liang H; Yang H; Lei D; Gao D; Long X; Chen Y; Zhu P; Chen X
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):199-204. PubMed ID: 22528220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
